Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8840129rdf:typepubmed:Citationlld:pubmed
pubmed-article:8840129lifeskim:mentionsumls-concept:C0999699lld:lifeskim
pubmed-article:8840129lifeskim:mentionsumls-concept:C0009368lld:lifeskim
pubmed-article:8840129lifeskim:mentionsumls-concept:C0205107lld:lifeskim
pubmed-article:8840129lifeskim:mentionsumls-concept:C0027793lld:lifeskim
pubmed-article:8840129lifeskim:mentionsumls-concept:C0299247lld:lifeskim
pubmed-article:8840129lifeskim:mentionsumls-concept:C0599668lld:lifeskim
pubmed-article:8840129pubmed:issue2lld:pubmed
pubmed-article:8840129pubmed:dateCreated1997-1-15lld:pubmed
pubmed-article:8840129pubmed:abstractTextThe pathways and possible transmitters involved in the contractile response to selective 5-HT3 and 5-HT4 receptor stimulation in the guinea-pig proximal colon were studied. In the presence of methysergide, 5-HT induced contractions, yielding a biphasic concentration-response curve that was changed into a monophasic curve in the presence of the 5-HT3 receptor antagonist, granisetron (1 microM) (low-affinity phase blocked), or the 5-HT4 receptor antagonist, SB 204070 ((1-butyl-4-piperidinyl methyl)-8-amino-7-chloro-1,4-benzodioxan-5-carboxylate) (10 nM) (high-affinity phase blocked) combination of the two antagonists abolished the contraction to 5-HT. The effectiveness and selectivity of both antagonists was confirmed by testing them against contractions in response to the 5-HT3 receptor-selective agonist, 2-methyl-5-HT, and the 5-HT4 receptor-selective agonist, 5-methoxytryptamine. Hexamethonium (100 microM) did not affect the 5-HT3 receptor-mediated contractions, whereas tetrodotoxin (0.3 microM) caused only slight inhibition. Both in the absence and presence of tetrodotoxin, atropine (0.3 microM) inhibited the 5-HT3 receptor-mediated contractions. Hence, the contractions to 5-HT are partly mediated by 5-HT3 receptors that are localized on the nerve endings of the motor neurons. Hexamethonium halved the 5-HT4 receptor-mediated contractions, whereas tetrodotoxin abolished them. The 5-HT4 receptor-mediated contractions were inhibited by atropine (0.3 microM). Thus, the 5-HT4 receptors seem to be localized in the soma of the motor neurons; they also occur on interneurons. The remaining contractions induced by 5-HT3 and 5-HT4 receptor stimulation in the presence of atropine were almost completely inhibited by the tachykinin NK1 receptor antagonist, CP 96345 ((2S,3S)-cis-2-(diphenyl methyl)-N-[(2-methoxy phenyl)-methyl]-1-azabicyclo-[2.2.2]-octan-3-amine) (0.1 microM). CP 96345 also abolished or strongly inhibited contractions in response to substance P (10 nM) and to neurokinin A (30 nM), but neither granisetron nor SB 204070 affected them. Hence, stimulation of either 5-HT3 or 5-HT4 receptors induced contractions that are partially mediated by acetylcholine, and partially by a tachykinin NK1 receptor-stimulating neurotransmitter, probably substance P and/or neurokinin A.lld:pubmed
pubmed-article:8840129pubmed:languageenglld:pubmed
pubmed-article:8840129pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:citationSubsetIMlld:pubmed
pubmed-article:8840129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8840129pubmed:statusMEDLINElld:pubmed
pubmed-article:8840129pubmed:monthJullld:pubmed
pubmed-article:8840129pubmed:issn0014-2999lld:pubmed
pubmed-article:8840129pubmed:authorpubmed-author:SchuurkesJ...lld:pubmed
pubmed-article:8840129pubmed:authorpubmed-author:BriejerM RMRlld:pubmed
pubmed-article:8840129pubmed:issnTypePrintlld:pubmed
pubmed-article:8840129pubmed:day18lld:pubmed
pubmed-article:8840129pubmed:volume308lld:pubmed
pubmed-article:8840129pubmed:ownerNLMlld:pubmed
pubmed-article:8840129pubmed:authorsCompleteYlld:pubmed
pubmed-article:8840129pubmed:pagination173-80lld:pubmed
pubmed-article:8840129pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:meshHeadingpubmed-meshheading:8840129-...lld:pubmed
pubmed-article:8840129pubmed:year1996lld:pubmed
pubmed-article:8840129pubmed:articleTitle5-HT3 and 5-HT4 receptors and cholinergic and tachykininergic neurotransmission in the guinea-pig proximal colon.lld:pubmed
pubmed-article:8840129pubmed:affiliationDepartment of Gastrointestinal Pharmacology, Janssen Research Foundation, Beerse, Belgium.lld:pubmed
pubmed-article:8840129pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8840129pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8840129pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8840129lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8840129lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8840129lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8840129lld:pubmed